Status:
TERMINATED
Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)
Lead Sponsor:
National Center for Complementary and Integrative Health (NCCIH)
Conditions:
Anxiety Disorders
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the safety and effectiveness of the herbal medicine kava kava for the treatment of generalized anxiety disorder (GAD).
Detailed Description
Kava kava (KAV) is a plant-derived treatment widely used in Europe to treat anxiety disorders. Several studies suggest that KAV may be effective in reducing anxiety symptoms; however, trial data are l...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosis of generalized anxiety disorder (GAD)
Exclusion
Key Trial Info
Start Date :
June 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2004
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00083980
Start Date
June 1 2002
End Date
August 1 2004
Last Update
October 19 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.